Form 4: BeOne Medicines Exec Sells Shares for Tax Withholding

BeOne Medicines President and COO Wu Xiaobin sold 1,292 American Depositary Shares for $276.2592 each to cover mandatory tax withholding obligations.

Summary

• Wu Xiaobin, President and COO of BeOne Medicines Ltd., sold 1,292 American Depositary Shares (ADS) on June 23, 2026.
• The sale was executed to satisfy mandatory tax withholding requirements related to a restricted share unit (RSU) award.
• The shares were sold at a weighted average price of $276.2592, with individual sales ranging from $276.23 to $276.475.
• Following the transaction, Wu Xiaobin beneficially owns 1,273,724 ordinary shares directly and 4,000 ADS indirectly through his wife.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was for mandatory tax withholding related to RSU vesting, a common and expected transaction for executives.

Negatives

• A company executive sold a portion of their holdings, which could be perceived negatively by the market, although it was for tax purposes.

Future Outlook

The filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine for executives and often relate to planned transactions like tax withholding, vesting, or diversification, rather than indicating a change in the executive's fundamental view of the company's prospects.

Stakeholder Impact

• Shareholders: The sale is for tax purposes and does not necessarily reflect a change in the executive's confidence in the company, thus likely minimal impact.

Key Dates

Keywords

BeOne Medicines, Form 4, Insider Trading, Stock Sale, Tax Withholding, Restricted Stock Units, American Depositary Shares, Wu Xiaobin